The Role of Plasminogen Activator Inhibitor-1 in Uveitis: Findings from Clinical and Experimental Studies.

Key Points

• This research aims to investigate the levels and implications of PAI-1 in uveitis.
• Measured PAI-1 levels in uveitis patients.
• Conducted experiments using animal models of experimental autoimmune uveitis (EAU).
• Applied PAI-1 inhibition techniques during EAU to assess effects.
• PAI-1 levels are significantly elevated in the eyes of uveitis patients.
• Inhibition of PAI-1 leads to reduction in EAU severity.
• Findings support PAI-1 as a potential therapeutic target for uveitis.